Article
The OPRM1 A118G Polymorphism Revisited: Recent Developments and Implications for Personalized Treatment.
Current pain and headache reports - 28 Apr 2026
Daybell Isaac, Wie Christopher, Johnson Brooks, Covington Stephen, Freeman John, Pew Scott, Maloney Jillian
Abstract excerpt
PURPOSE OF REVIEW: The OPRM1 A118G polymorphism, a single nucleotide variation in the mu-opioid receptor (MOR) gene, has been investigated for its role in opioid efficacy, addiction vulnerability, opioid-related adverse effects, and patient behavior. This review synthesizes recent findings, with a focus on clinical implications for patients with this polymorphism. RECENT FINDINGS: Recent research into the OPRM1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
